Skip to main content
Log in

Transdermal oestrogene application a contraindication in therapy of endometriosis with Gonadotropin-Releasing Hormon analogues

  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Barbieri RL (1988) New therapy for endometriosis. N Engl J Med 318:512–514

    Google Scholar 

  2. Maouris P (1989) A new treatment for Endometriosis. The Lancet 1:1017–1018

    Google Scholar 

  3. Matta WH, Shaw RW, Hesp R, Katz D (1987) Hypogonadism induced by hormone relesing hormone agonist analogues: effects on bone density in premenopausal women. Br Med J 294:1523

    Google Scholar 

  4. Meldrum DR, Chan RJ, Lu J, Vale W, Rivier J, Judd HL (1982) “Medical oophorectomy” using a long-acting GnRH agonist — a possible new approch to the treatment of endometriosis. J Clin Endocrinol Metab 54:1081

    Google Scholar 

  5. DiZerega GS, Barber DL, Hodgen GD (1980) Enometriosis: role of ovarian steroids in initiation, maintence and suppresion. Fertil Steril 33:649–653

    Google Scholar 

  6. Roddick JW, Conkey G, Jacobs EJ (1960) The hormonal response of enodometrotic implants and its relationship to symptomatology. Am J Obstet Gynecol 79:1173

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rosen, A., Klein, M. & Beck, A. Transdermal oestrogene application a contraindication in therapy of endometriosis with Gonadotropin-Releasing Hormon analogues. Klin Wochenschr 68, 537 (1990). https://doi.org/10.1007/BF01648254

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01648254

Keywords

Navigation